Baptist Clinical Research Institute Inc
Memphis, Tennessee
Financial Health Score
9-metric score across financial health, operational efficiency, and organizational resilience. Based on IRS Form 990 data.
Poor
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Filing History
11 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2023 | $2,161,067โ20% | $4,263,925โ2% | $455,611โ10% | โ |
| 2022 | $1,800,525โ9% | $4,347,213โ10% | $507,696โ231% | โ |
| 2021 | $1,977,517โ14% | $3,957,317โ23% | $153,363โ11% | โ |
| 2020 | $1,729,642โ14% | $3,213,146โ8% | $138,519โ6% | โ |
| 2019 | $2,016,558โ69% | $3,490,797โ17% | $130,843โ46% | โ |
| 2018 | $1,194,241โ21% | $2,996,206โ4% | $241,554โ31% | โ |
| 2017 | $1,508,032โ174% | $2,890,290โ131% | $348,638โ55% | โ |
| 2016 | $550,645โ10% | $1,253,149โ42% | $225,389โ174% | โ |
| 2015 | $501,326โ16% | $882,256โ38% | $82,314โ747% | โ |
| 2014 | $432,289โ146% | $639,215โ12% | $9,717โ9% | โ |
| 2013 | $175,434 | $725,514 | $10,667 | โ |
Frequently Asked Questions
What does Baptist Clinical Research Institute Inc do?โผ
Baptist Clinical Research Institute Inc is a science & technology nonprofit organization based in Tennessee. It is classified under NTEE code U05 and is registered as a 501(c) tax-exempt organization with the IRS.
Is Baptist Clinical Research Institute Inc financially healthy?โผ
Based on our 9-metric Financial Health Score model, Baptist Clinical Research Institute Inc has a score of 32/100 (Grade: D). This score evaluates working capital, surplus consistency, debt ratio, revenue trends, program spending, fundraising efficiency, executive compensation, revenue diversification, and vulnerability indicators.
How much revenue does Baptist Clinical Research Institute Inc generate?โผ
Baptist Clinical Research Institute Inc reports $2.2M in annual revenue and holds $401K in total assets, based on IRS filings.
Similar Organizations
Explore more organizations in the Science & Technology category, or browse all nonprofits in Tennessee.